Rafferty Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,260
Closed -$577K 1016
2020
Q1
$577K Sell
3,260
-7,768
-70% -$1.46M 0.02% 307
2019
Q4
$2.11M Buy
11,028
+7,384
+203% +$1.33M 0.03% 370
2019
Q3
$613K Buy
3,644
+952
+35% +$155K 0.01% 634
2019
Q2
$451K Buy
+2,692
New +$373K 0.01% 708
2019
Q1
Sell
-13,799
Closed -$1.84M 861
2018
Q4
$1.84M Buy
+13,799
New +$2.26M 0.04% 210
2018
Q2
Sell
-30,954
Closed -$5.21M 721
2018
Q1
$5.21M Buy
30,954
+27,945
+929% +$4.69M 0.08% 128
2017
Q4
$492K Buy
3,009
+1,079
+56% +$194K 0.01% 564
2017
Q3
$396K Sell
1,930
-245
-11% -$57K 0.01% 542
2017
Q2
$529K Sell
2,175
-3,242
-60% -$762K 0.02% 481
2017
Q1
$1.29M Buy
5,417
+3,109
+135% +$724K 0.03% 258
2016
Q4
$485K Buy
2,308
+128
+6% +$26.5K 0.02% 318
2016
Q3
$502K Sell
2,180
-372
-15% -$90.9K 0.02% 356
2016
Q2
$590K Buy
2,552
+167
+7% +$38.5K 0.04% 325
2016
Q1
$639K Sell
2,385
-286
-11% -$81.9K 0.03% 367
2015
Q4
$835K Sell
2,671
-2,110
-44% -$628K 0.1% 267
2015
Q3
$1.3M Buy
4,781
+373
+8% +$115K 0.1% 183
2015
Q2
$1.34M Sell
4,408
-1,734
-28% -$517K 0.09% 162
2015
Q1
$1.83M Buy
+6,142
New +$1.75M 0.14% 107

Other funds holding AGN

Rafferty Asset Management's AGN Position: Q2 2020 in Review

Rafferty Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,260 shares — an estimated $577K sold.

Rafferty Asset Management first reported a position in AGN in Q1 2015 and held it in 18 quarters. The position peaked at $5.21M in Q1 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Rafferty Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Rafferty Asset Management sold 3,260 Allergan plc shares in Q2 2020, an estimated $577K.
  • Rafferty Asset Management first reported a position in Allergan plc in Q1 2015 and held it in 18 quarters.
  • Rafferty Asset Management's Allergan plc position peaked at $5.21M in Q1 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Rafferty Asset Management's 13F filing for Q2 2020, filed 7 Aug 2020.